Electronic and software design company based in Oxfordshire, Neutronix has developed a new infection prevention solution in collaboration with Clean Air UK.
Designed for enclosed spaces such as hospital wards, the clinical air filtration device removes airborne organic matter, reducing secondary infection change.
The first data from the initial tests at Cambridge University Hospitals is described as “positive”, especially with regard to SARS-CoV2. The system actively analyzes the air levels and reacts in real time when it detects a risk by modifying the airflows.
Neutronix Ltd CEO Francesco Poderico said, “We have extensive experience in the design of custom electronic components and printed circuit boards. The Air Filtration System is such a rewarding project to be part of and it’s great to have been part of the journey leading electronic design through the development cycle from concept to production.
Read more – Harwell’s Helix Geospace secures space on Future Flights challenge project
Full test results are expected to be released in spring 2023. In addition to hospitals, the filtration system could be installed in clinical laboratories, nursing homes and schools, both domestically and internationally.
Heyford Park’s Chief Innovation Officer, Wendy Tindsley, said: “This innovative solution shows that relatively small businesses can play a huge role in solving real-world problems and having a positive impact on lives.
“We are extremely proud that the Heyford Park Innovation Center facilities have contributed to this breakthrough, and hope that it will inspire other companies and start-ups to pursue their innovative ideas.
“I can’t wait to see how it will progress and how it will get the recognition it deserves. The world is literally waiting for something like this.
Read more – Government announces winners of £11m funding pot to support food sector innovation
Comments are closed.